SCHEDULE: Flora Growth Grants CEO Heinrich 471K Stock Options

Flora Growth Corp. granted its Chairman and CEO, Michael Heinrich, 471,208 stock options with an exercise price of $7.31 per share, vesting upon specific volume weighted average price thresholds.

Summary

• Michael Heinrich, CEO of Zero Gravity Labs Inc. and Chairman of the Board of Flora Growth Corp., was granted 471,208 stock options by Flora Growth Corp. on December 19, 2025.
• The options have an exercise price of $7.31 per share.
• Vesting occurs in five equal 20% installments, contingent on Flora Growth's common stock reaching Volume Weighted Average Price (VWAP) thresholds of $10.97, $14.62, $18.28, $21.93, and $25.59.
• Following this grant, Michael Heinrich beneficially owns 5,373,428 common shares, representing 86.4% of Flora Growth Corp.'s class.
• Zero Gravity Labs Inc. beneficially owns 4,902,220 common shares, representing 85.3% of the class, with shared voting and dispositive power.

Sentiment

Score: 7

Explanation: The grant of performance-based stock options with high vesting thresholds suggests management's confidence in future growth and aligns executive incentives with shareholder interests. However, the high concentration of ownership could be a concern for some investors.

Positives

• The grant of performance-based stock options aligns management's incentives with long-term shareholder value creation, as vesting is tied to significant stock price appreciation.
• The high VWAP thresholds required for full vesting ($10.97 to $25.59) indicate management's confidence in substantial future growth.

Negatives

• The high percentage of beneficial ownership (86.4% for Heinrich, 85.3% for Zero Gravity Labs Inc.) could raise concerns about liquidity and control concentration for other shareholders.

Risks

• Achievement of the stock option vesting thresholds is uncertain and depends on significant future appreciation of Flora Growth Corp.'s common stock, which may not occur.
• The concentration of beneficial ownership by Michael Heinrich and Zero Gravity Labs Inc. (86.4% and 85.3% respectively) could lead to reduced liquidity for other shareholders and significant control by a single entity/individual.

Future Outlook

The performance-based vesting conditions for the stock options, tied to increasing Volume Weighted Average Price (VWAP) thresholds up to $25.59, imply an expectation of significant future stock price appreciation for Flora Growth Corp.

Industry Context

This filing is specific to executive compensation and beneficial ownership within Flora Growth Corp. It does not provide broader industry trends or competitive analysis.

Corporate Governance

Legal Proceedings

• Neither Michael Heinrich nor Zero Gravity Labs Inc. have been convicted in a criminal proceeding (excluding traffic violations) or been a party to a civil proceeding related to federal or state securities laws in the last five years.

Related Party Transactions

• The stock option grant to Michael Heinrich, who is the Chairman and a director of Flora Growth Corp., constitutes a related party transaction.

Stakeholder Impact

• Shareholders: Potential for increased shareholder value if the stock price reaches the high VWAP vesting thresholds, aligning management's interests. However, the high concentration of ownership by Michael Heinrich and Zero Gravity Labs Inc. could impact liquidity and control.
• Management (Michael Heinrich): Significant incentive to drive stock price appreciation due to performance-based option vesting.

Next Steps

• Michael Heinrich will continue to serve as CEO of Zero Gravity Labs Inc. and Chairman of the Board of Flora Growth Corp.
• The granted stock options will vest in five equal installments upon Flora Growth's common stock achieving specified VWAP thresholds.

Key Dates

Recommendation

The grant of performance-based stock options to the Chairman and CEO, Michael Heinrich, with challenging VWAP vesting thresholds, indicates a strong alignment of management incentives with long-term shareholder value creation. This could be a positive catalyst for future stock performance. However, the very high beneficial ownership percentage by Michael Heinrich and Zero Gravity Labs Inc. (over 85%) could raise concerns about market liquidity and corporate control. Investors should monitor the company's operational performance and progress towards these stock price targets, while also considering the implications of such concentrated ownership. Therefore, a 'hold' recommendation is appropriate, awaiting further developments and market response.

Keywords

Flora Growth Corp., Michael Heinrich, Zero Gravity Labs Inc., Schedule 13D, Stock Options, Beneficial Ownership, Corporate Governance, Executive Compensation, VWAP, SEC Filing